Non-virally mediated gene transfer into human central nervous system precursor cells

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Human central nervous system (CNS) precursor cells are crucial for neural development and disease modeling.
• Efficient gene delivery methods are essential for studying CNS cell differentiation and function.
• Understanding CNS precursor cell potential is key to regenerative medicine and neurological disorder research.

Purpose of the Study:

• To evaluate Lipofectamine as a method for delivering genes into human CNS precursor cells.
• To assess the differentiation potential of transfected CNS precursor cells.
• To investigate the expression and effects of SV40 Large-T antigen in these cells.

Main Methods:

• Lipofectamine-based transfection was employed to introduce the bacterial beta-galactosidase gene.
• Transfection efficiency was quantified.
• Immunohistochemistry was used to detect beta-galactosidase expression and assess cell phenotypes (neuronal and glial).
• The temperature-sensitive allele of SV40 Large-T antigen was delivered to evaluate immortalization potential.

Main Results:

• A transfection efficiency of 7.4% was achieved using Lipofectamine.
• beta-Galactosidase expressing cells exhibited both neuronal and glial characteristics.
• High-level expression of the SV40 Large-T antigen oncoprotein was obtained.
• Visible colonies of Large-T antigen immunoreactive cells were observed 10 days post-transfection.

Conclusions:

• Lipofectamine is an effective tool for gene delivery into human CNS precursor cells.
• Transfected CNS precursor cells can differentiate into neuronal and glial lineages.
• SV40 Large-T antigen expression can lead to the immortalization of these CNS precursor cells, facilitating further study.